Brian K. Halak, 10% Owner at Durata Therapeutics, Inc. (DRTX), bought 800,842 shares at $9.00 ($7.1M) on 2012-07-24, disclosed to the SEC on 2012-07-24.
Open-market purchase of $7.1M DRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 16,529 | $0 | 0.0% |
| 2 | $9.00 | 5,777 | $52K | 0.7% |
| 3 | $9.00 | 778,536 | $7.0M | 99.3% |
| Total | $8.81 avg | 800,842 | $7.1M | 100% |
| Filing → |
| DRNA | SELL | 2018-11-01 | $2.5M | — | Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |